LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 83713

Suchoptionen

  1. Artikel ; Online: Retraction Note: Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.

    Liu, Cheng / Yuan, Xia / Tao, Le / Cheng, Zhuoan / Dai, Xiuqin / Sheng, Xia / Xue, Dongying

    BMC complementary medicine and therapies

    2022  Band 22, Heft 1, Seite(n) 236

    Sprache Englisch
    Erscheinungsdatum 2022-09-06
    Erscheinungsland England
    Dokumenttyp Retraction of Publication
    ISSN 2662-7671
    ISSN (online) 2662-7671
    DOI 10.1186/s12906-022-03714-x
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exploiting Nonclassical Interactions.

    Xu, Guozhang / Liu, Zhijie / Wang, Xinkang / Lu, Tianbao / DesJarlais, Renee L / Thieu, Tho / Zhang, Jing / Devine, Zheng Huang / Du, Fuyong / Li, Qiu / Milligan, Cynthia M / Shaffer, Paul / Cedervall, Peder E / Spurlino, John C / Stratton, Christopher F / Pietrak, Beth / Szewczuk, Lawrence M / Wong, Victoria / Steele, Ruth A /
    Bruinzeel, Wouter / Chintala, Madhu / Silva, Jose / Gaul, Michael D / Macielag, Mark J / Nargund, Ravi

    Journal of medicinal chemistry

    2022  Band 65, Heft 15, Seite(n) 10419–10440

    Abstract: Activated factor XI (FXIa) inhibitors are promising novel anticoagulants with low bleeding risk compared with current anticoagulants. The discovery of potent FXIa inhibitors with good oral bioavailability has been challenging. Herein, we describe our ... ...

    Abstract Activated factor XI (FXIa) inhibitors are promising novel anticoagulants with low bleeding risk compared with current anticoagulants. The discovery of potent FXIa inhibitors with good oral bioavailability has been challenging. Herein, we describe our discovery effort, utilizing nonclassical interactions to improve potency, cellular permeability, and oral bioavailability by enhancing the binding while reducing polar atoms. Beginning with literature-inspired pyridine N-oxide-based FXIa inhibitor
    Mesh-Begriff(e) Animals ; Anticoagulants/chemistry ; Anticoagulants/pharmacology ; Dogs ; Drug Design ; Factor XIa/metabolism ; Pyridines/pharmacology ; Rabbits ; Rats
    Chemische Substanzen Anticoagulants ; Pyridines ; pyridine N-oxide (91F12JJJ4H) ; Factor XIa (EC 3.4.21.27)
    Sprache Englisch
    Erscheinungsdatum 2022-07-21
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.2c00442
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel: Investigating the mechanism of Xian-ling-lian-xia-fang for inhibiting vasculogenic mimicry in triple negative breast cancer via blocking VEGF/MMPs pathway.

    Li, Feifei / Shi, Youyang / Zhang, Yang / Yang, Xiaojuan / Wang, Yi / Jiang, Kexin / Hua, Ciyi / Wu, Chunyu / Sun, Chenping / Qin, Yuenong / Liu, Sheng

    Chinese medicine

    2022  Band 17, Heft 1, Seite(n) 44

    Abstract: Background: Xian-ling-lian-xia-fang (XLLXF), a Chinese medicine decoction, is widely used ...

    Abstract Background: Xian-ling-lian-xia-fang (XLLXF), a Chinese medicine decoction, is widely used in the treatment of triple negative breast cancer (TNBC). However, the underlying mechanism of XLLXF in TNBC treatment has not been totally elucidated.
    Methods: Here, network pharmacology and molecular docking were used to explore the mechanism of Traditional Chinese medicine in the treatment of TNBC. Then, biological experiments were integrated to verify the results of network pharmacology.
    Results: Network pharmacology showed that the candidate active ingredients mainly included quercetin, kaempferol, stigmasterol, and β-sitosterol through the "XLLXF-active ingredients-targets" network. Vascular endothelial growth factor A (VEGFA) and matrix metalloproteinase (MMP) 2 were the potential therapeutic targets obtained through the protein-protein interaction (PPI) network. Molecular docking confirmed that quercetin, kaempferol, stigmasterol, and β-sitosterol could stably combine with VEGFA and MMP2. Experimental verification showed that XLLXF could inhibit proliferation, colony ability, and vasculogenic mimicry (VM) formation and promote cell apoptosis in TNBC. Laser confocal microscopy found that XLLXF impaired F-actin cytoskeleton organization and inhibited epithelial mesenchymal transition. Animal experiments also found that XLLXF could inhibit tumor growth and VM formation in TNBC xenograft model. Western blot analysis and immunohistochemical staining showed that XLLXF inhibited the protein expression of VEGFA, MMP2, MMP9, Vimentin, VE-cadherin, and Twist1 and increased that of E-cadherin, tissue inhibitors of metalloproteinase (TIMP)-1, and TIMP-3 in vitro and in vivo.
    Conclusions: Integrating the analysis of network pharmacology and experimental validation revealed that XLLXF could inhibit VM formation via downregulating the VEGF/MMPs signaling pathway.
    Sprache Englisch
    Erscheinungsdatum 2022-04-04
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2260322-0
    ISSN 1749-8546
    ISSN 1749-8546
    DOI 10.1186/s13020-022-00597-5
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel: Transcriptome-Wide m6A Analysis Provides Novel Insights Into Testicular Development and Spermatogenesis in Xia-Nan Cattle.

    Liu, Shen-He / Ma, Xiao-Ya / Yue, Ting-Ting / Wang, Zi-Chen / Qi, Kun-Long / Li, Ji-Chao / Lin, Feng / Rushdi, Hossam E / Gao, Yu-Yang / Fu, Tong / Li, Ming / Gao, Teng-Yun / Yang, Li-Guo / Han, Xue-Lei / Deng, Ting-Xian

    Frontiers in cell and developmental biology

    2021  Band 9, Seite(n) 791221

    Abstract: Testis is the primary organ of the male reproductive tract in mammals that plays a substantial role in spermatogenesis. Improvement of our knowledge regarding the molecular mechanisms in testicular development and spermatogenesis will be reflected in ... ...

    Abstract Testis is the primary organ of the male reproductive tract in mammals that plays a substantial role in spermatogenesis. Improvement of our knowledge regarding the molecular mechanisms in testicular development and spermatogenesis will be reflected in producing spermatozoa of superior fertility. Evidence showed that N6-Methyladenosine (m6A) plays a dynamic role in post-transcription gene expression regulation and is strongly associated with production traits. However, the role of m6A in bovine testis has not been investigated yet. In this study, we conducted MeRIP-Seq analysis to explore the expression profiles of the m6A and its potential mechanism underlying spermatogenesis in nine bovine testes at three developmental stages (prepuberty, puberty and postpuberty). The experimental animals with triplicate in each stage were chosen based on their semen volume and sperm motility except for the prepuberty bulls and used for testes collection. By applying MeRIP-Seq analysis, a total of 8,774 m6A peaks and 6,206 m6A genes among the studied groups were identified. All the detected peaks were found to be mainly enriched in the coding region and 3'- untranslated regions. The cross-analysis of m6A and mRNA expression exhibited 502 genes with concomitant changes in the mRNA expression and m6A modification. Notably, 30 candidate genes were located in the largest network of protein-protein interactions. Interestingly, four key node genes (
    Sprache Englisch
    Erscheinungsdatum 2021-12-22
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2737824-X
    ISSN 2296-634X
    ISSN 2296-634X
    DOI 10.3389/fcell.2021.791221
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Design and synthesis of novel proline based factor XIa selective inhibitors as leads for potential new anticoagulants.

    Hussain, Zahid / Cooke, Andrew J / Neelamkavil, Santhosh / Brown, Lindsay / Carswell, Emma / Geissler, Wayne M / Guo, Zhuyan / Hawes, Brian / Kelly, Terri M / Kiyoi, Yasuko / Lai, KehDih / Lesburg, Charles / Pow, Eleanor / Zang, Yi / Wood, Harold B / Edmondson, Scott D / Liu, Weiguo

    Bioorganic & medicinal chemistry letters

    2020  Band 30, Heft 16, Seite(n) 127072

    Abstract: ... inhibition of blood coagulation factor XIa in search of new non-vitamin K antagonists based oral anticoagulants for potential prevention ...

    Abstract A series of 4, 4-disubstituted proline analogs were designed, synthesized, and tested for selective inhibition of blood coagulation factor XIa in search of new non-vitamin K antagonists based oral anticoagulants for potential prevention and treatment of thrombotic diseases. Starting from a potent thrombin (FIIa) inhibitor chemotype with FIIa IC
    Mesh-Begriff(e) Anticoagulants/chemical synthesis ; Anticoagulants/chemistry ; Anticoagulants/pharmacology ; Dose-Response Relationship, Drug ; Drug Design ; Factor XIa/antagonists & inhibitors ; Factor XIa/metabolism ; Humans ; Molecular Structure ; Proline/chemical synthesis ; Proline/chemistry ; Proline/pharmacology ; Structure-Activity Relationship
    Chemische Substanzen Anticoagulants ; Proline (9DLQ4CIU6V) ; Factor XIa (EC 3.4.21.27)
    Sprache Englisch
    Erscheinungsdatum 2020-02-29
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 1063195-1
    ISSN 1464-3405 ; 0960-894X
    ISSN (online) 1464-3405
    ISSN 0960-894X
    DOI 10.1016/j.bmcl.2020.127072
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Mitigating Spatial Conflict of Land Use for Sustainable Wetlands Landscape in Li-Xia-River Region of Central Jiangsu, China

    Yan Sun / Xiaoping Ge / Junna Liu / Yuanyuan Chang / Gang-Jun Liu / Fu Chen

    Sustainability, Vol 13, Iss 11189, p

    2021  Band 11189

    Abstract: Li-Xia-river Wetlands make up the biggest freshwater marsh in East China. Over the last decades ... model with the purpose of quantitatively evaluating the intensity of land use conflict in Li-Xia-river ... threat to Li-Xia-river Wetlands. Coordinating land use conflict and formulating a practical strategy are ...

    Abstract Li-Xia-river Wetlands make up the biggest freshwater marsh in East China. Over the last decades, social and economic developments have dramatically altered the natural wetlands landscape. Mitigating land use conflict is beneficial to protect wetlands, maintain ecosystem services, and coordinate local socioeconomic development. This study employed multi-source data and GIS-based approaches to construct a composite index model with the purpose of quantitatively evaluating the intensity of land use conflict in Li-Xia-river Wetlands from 1978 to 2018. The results showed that the percentage of the wetlands’ area declined from 20.3% to 15.6%, with an overall reduction rate of 23.2%. The mean index of land use conflict increased from 0.15 to 0.35, which suggests that the conflict intensity changed from “no conflict” to “mild conflict.” The number of severe conflict units increased by about 25 times. A conspicuous spatial variation of land use conflict was observed across different periods, although taking land for agricultural activities was the overriding reason for wetlands reduction. However, in recent years, urban sprawl has posed the greatest threat to Li-Xia-river Wetlands. Coordinating land use conflict and formulating a practical strategy are the initial imperative steps to mitigate the threat to wetlands.
    Schlagwörter Li-Xia-river Wetlands ; land use conflict ; urban sprawl ; wetland protection ; ecological service ; Environmental effects of industries and plants ; TD194-195 ; Renewable energy sources ; TJ807-830 ; Environmental sciences ; GE1-350
    Thema/Rubrik (Code) 710 ; 333
    Sprache Englisch
    Erscheinungsdatum 2021-10-01T00:00:00Z
    Verlag MDPI AG
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Investigating the mechanism of Xian-ling-lian-xia-fang for inhibiting vasculogenic mimicry in triple negative breast cancer via blocking VEGF/MMPs pathway

    Feifei Li / Youyang Shi / Yang Zhang / Xiaojuan Yang / Yi Wang / Kexin Jiang / Ciyi Hua / Chunyu Wu / Chenping Sun / Yuenong Qin / Sheng Liu

    Chinese Medicine, Vol 17, Iss 1, Pp 1-

    2022  Band 20

    Abstract: Abstract Background Xian-ling-lian-xia-fang (XLLXF), a Chinese medicine decoction, is widely used ...

    Abstract Abstract Background Xian-ling-lian-xia-fang (XLLXF), a Chinese medicine decoction, is widely used in the treatment of triple negative breast cancer (TNBC). However, the underlying mechanism of XLLXF in TNBC treatment has not been totally elucidated. Methods Here, network pharmacology and molecular docking were used to explore the mechanism of Traditional Chinese medicine in the treatment of TNBC. Then, biological experiments were integrated to verify the results of network pharmacology. Results Network pharmacology showed that the candidate active ingredients mainly included quercetin, kaempferol, stigmasterol, and β-sitosterol through the “XLLXF–active ingredients–targets” network. Vascular endothelial growth factor A (VEGFA) and matrix metalloproteinase (MMP) 2 were the potential therapeutic targets obtained through the protein–protein interaction (PPI) network. Molecular docking confirmed that quercetin, kaempferol, stigmasterol, and β-sitosterol could stably combine with VEGFA and MMP2. Experimental verification showed that XLLXF could inhibit proliferation, colony ability, and vasculogenic mimicry (VM) formation and promote cell apoptosis in TNBC. Laser confocal microscopy found that XLLXF impaired F-actin cytoskeleton organization and inhibited epithelial mesenchymal transition. Animal experiments also found that XLLXF could inhibit tumor growth and VM formation in TNBC xenograft model. Western blot analysis and immunohistochemical staining showed that XLLXF inhibited the protein expression of VEGFA, MMP2, MMP9, Vimentin, VE-cadherin, and Twist1 and increased that of E-cadherin, tissue inhibitors of metalloproteinase (TIMP)-1, and TIMP-3 in vitro and in vivo. Conclusions Integrating the analysis of network pharmacology and experimental validation revealed that XLLXF could inhibit VM formation via downregulating the VEGF/MMPs signaling pathway.
    Schlagwörter Chinese medicine decoction ; Triple-negative breast cancer ; Vascular mimicry ; Network pharmacology ; Experimental validation ; Other systems of medicine ; RZ201-999
    Thema/Rubrik (Code) 616
    Sprache Englisch
    Erscheinungsdatum 2022-04-01T00:00:00Z
    Verlag BMC
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Transcriptome-Wide m6A Analysis Provides Novel Insights Into Testicular Development and Spermatogenesis in Xia-Nan Cattle

    Shen-he Liu / Xiao-ya Ma / Ting-ting Yue / Zi-chen Wang / Kun-long Qi / Ji-chao Li / Feng Lin / Hossam E. Rushdi / Yu-yang Gao / Tong Fu / Ming Li / Teng-yun Gao / Li-guo Yang / Xue-lei Han / Ting-xian Deng

    Frontiers in Cell and Developmental Biology, Vol

    2021  Band 9

    Abstract: Testis is the primary organ of the male reproductive tract in mammals that plays a substantial role in spermatogenesis. Improvement of our knowledge regarding the molecular mechanisms in testicular development and spermatogenesis will be reflected in ... ...

    Abstract Testis is the primary organ of the male reproductive tract in mammals that plays a substantial role in spermatogenesis. Improvement of our knowledge regarding the molecular mechanisms in testicular development and spermatogenesis will be reflected in producing spermatozoa of superior fertility. Evidence showed that N6-Methyladenosine (m6A) plays a dynamic role in post-transcription gene expression regulation and is strongly associated with production traits. However, the role of m6A in bovine testis has not been investigated yet. In this study, we conducted MeRIP-Seq analysis to explore the expression profiles of the m6A and its potential mechanism underlying spermatogenesis in nine bovine testes at three developmental stages (prepuberty, puberty and postpuberty). The experimental animals with triplicate in each stage were chosen based on their semen volume and sperm motility except for the prepuberty bulls and used for testes collection. By applying MeRIP-Seq analysis, a total of 8,774 m6A peaks and 6,206 m6A genes among the studied groups were identified. All the detected peaks were found to be mainly enriched in the coding region and 3′- untranslated regions. The cross-analysis of m6A and mRNA expression exhibited 502 genes with concomitant changes in the mRNA expression and m6A modification. Notably, 30 candidate genes were located in the largest network of protein-protein interactions. Interestingly, four key node genes (PLK4, PTEN, EGR1, and PSME4) were associated with the regulation of mammal testis development and spermatogenesis. This study is the first to present a map of RNA m6A modification in bovine testes at distinct ages, and provides new insights into m6A topology and related molecular mechanisms underlying bovine spermatogenesis, and establishes a basis for further studies on spermatogenesis in mammals.
    Schlagwörter cattle ; testis ; m6A modification ; spermatogenesis ; semen quality ; sequencing ; Biology (General) ; QH301-705.5
    Thema/Rubrik (Code) 572
    Sprache Englisch
    Erscheinungsdatum 2021-12-01T00:00:00Z
    Verlag Frontiers Media S.A.
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach.

    Lorthiois, Edwige / Roache, James / Barnes-Seeman, David / Altmann, Eva / Hassiepen, Ulrich / Turner, Gordon / Duvadie, Rohit / Hornak, Viktor / Karki, Rajeshri G / Schiering, Nikolaus / Weihofen, Wilhelm A / Perruccio, Francesca / Calhoun, Amy / Fazal, Tanzina / Dedic, Darija / Durand, Corinne / Dussauge, Solene / Fettis, Kamal / Tritsch, Fabien /
    Dentel, Celine / Druet, Adelaide / Liu, Donglei / Kirman, Louise / Lachal, Julie / Namoto, Kenji / Bevan, Douglas / Mo, Rose / Monnet, Gabriela / Muller, Lionel / Zessis, Richard / Huang, Xueming / Lindsley, Loren / Currie, Treeve / Chiu, Yu-Hsin / Fridrich, Cary / Delgado, Peter / Wang, Shuangxi / Hollis-Symynkywicz, Micah / Berghausen, Joerg / Williams, Eric / Liu, Hong / Liang, Guiqing / Kim, Hyungchul / Hoffmann, Peter / Hein, Andreas / Ramage, Paul / D'Arcy, Allan / Harlfinger, Stefanie / Renatus, Martin / Ruedisser, Simon / Feldman, David / Elliott, Jason / Sedrani, Richard / Maibaum, Juergen / Adams, Christopher M

    Journal of medicinal chemistry

    2020  Band 63, Heft 15, Seite(n) 8088–8113

    Abstract: The serine protease factor XI (FXI) is a prominent drug target as it holds promise to deliver efficacious anticoagulation without an enhanced risk of major bleeds. Several efforts have been described targeting the active form of the enzyme, FXIa. Herein, ...

    Abstract The serine protease factor XI (FXI) is a prominent drug target as it holds promise to deliver efficacious anticoagulation without an enhanced risk of major bleeds. Several efforts have been described targeting the active form of the enzyme, FXIa. Herein, we disclose our efforts to identify potent, selective, and orally bioavailable inhibitors of FXIa. Compound
    Mesh-Begriff(e) Administration, Oral ; Amino Acid Sequence ; Animals ; Biological Availability ; Dogs ; Drug Evaluation, Preclinical/methods ; Factor XIa/antagonists & inhibitors ; Factor XIa/genetics ; Factor Xa Inhibitors/administration & dosage ; Factor Xa Inhibitors/chemistry ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Rats ; Rats, Sprague-Dawley ; Structure-Activity Relationship
    Chemische Substanzen Factor Xa Inhibitors ; Factor XIa (EC 3.4.21.27)
    Sprache Englisch
    Erscheinungsdatum 2020-07-21
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.0c00279
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Ultrasonic evaluation of central retinal artery hemodynamics in patients with hypertensive disorder complicating pregnancy and the correlation with diseaseChen-Xia Liu, Jing-Mian Zhou

    Chen-Xia Liu

    Journal of Hainan Medical University, Vol 23, Iss 1, Pp 139-

    2017  Band 142

    Abstract: Objective: To study the correlation between central retinal artery hemodynamic characteristics in patients with hypertensive disorder complicating pregnancy and endothelial injury molecules as well as trophoblast cell apoptosis molecules. Methods: 45 ... ...

    Abstract Objective: To study the correlation between central retinal artery hemodynamic characteristics in patients with hypertensive disorder complicating pregnancy and endothelial injury molecules as well as trophoblast cell apoptosis molecules. Methods: 45 healthy pregnant women, 37 patients with gestational hypertension and 24 patients with preeclampsia who gave birth in Obstetrics Department of our hospital between May 2013 and December 2015 were selected and included in the control group, GH group and PE group respectively. Central retinal artery ultrasonography was done to determine peak systolic velocity (PSV), end-diastolic velocity (EDV) and resistance index (RI), serum was collected to determine interleukin-6 (IL-6), IL- 17, IL-24, chemokine ligand 10 (CXCL10) and cartilage glycoprotein 40 (YKL40) content, and placenta tissue was collected to determine Fas, FasL, Bax, Caspase-3, Caspase-9, XIAP, Survivin and Livin expression. Results: Central retinal artery PSV and EDV as well as XIAP, Survivin and Livin expression in placenta of GH group and PE group were significantly lower than those of control group (P<0.05) while central retinal artery RI, serum IL-6, IL- 17, IL-24, CXCL10 and YKL40 content as well as Fas, FasL, Bax, Caspase-3 and Caspase-9 expression in placenta were significantly higher than those of control group (P<0.05). Central retinal artery PSV and EDV as well as XIAP, Survivin and Livin expression in placenta of PE group were significantly lower than those of GH group (P<0.05) while central retinal artery RI, serum IL-6, IL-17, IL-24, CXCL10 and YKL40 content as well as Fas, FasL, Bax, Caspase-3 and Caspase-9 expression in placenta were significantly higher than those of GH group (P<0.05). Serum IL-6, IL-17, IL-24, CXCL10 and YKL40 content as well as Fas, FasL, Bax, Caspase-3 and Caspase-9 expression in placenta were negatively correlated with PSV and EDV, and positively correlated with RI; XIAP, Survivin and Livin expression in placenta were positively correlated with PSV and EDV, and negatively correlated with RI. Conclusions: Central retinal artery blood flow characteristics in patients with hypertensive disorder complicating pregnancy are the significantly increased blood flow resistance and the significantly decreased blood flow volume, and the above blood flow characteristics are associated with maternal endothelial injury and trophoblast cell apoptosis.
    Schlagwörter Hypertensive disorder complicating pregnancy ; Central retinal artery ; Endothelial injury ; Cell apoptosis ; Medicine ; R
    Thema/Rubrik (Code) 610
    Sprache Englisch
    Erscheinungsdatum 2017-01-01T00:00:00Z
    Verlag Editorial Board of Journal of Hainan Medical University
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang